These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8989237)

  • 21. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers.
    Harvey RD; McHardy KC; Reid IW; Paterson F; Bewsher PD; Duncan A; Robins SP
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1189-94. PubMed ID: 2026741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
    Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women.
    Gürlek A; Gedik O
    Thyroid; 1999 Jun; 9(6):539-43. PubMed ID: 10411115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone metabolism in premenopausal women with nontoxic goiter and reduced serum thyrotropin levels.
    Faber J; Overgaard K; Jarløv AE; Christiansen C
    Thyroidology; 1994 Apr; 6(1):27-32. PubMed ID: 7536445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
    Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
    Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
    Terzi T; Terzi M; Tander B; Cantürk F; Onar M
    J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum bone Gla protein: a marker of bone turnover in hyperthyroidism.
    Garrel DR; Delmas PD; Malaval L; Tourniaire J
    J Clin Endocrinol Metab; 1986 May; 62(5):1052-5. PubMed ID: 3485649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma.
    De Menis E; Da Rin G; Roiter I; Legovini P; Foscolo G; Conte N
    Horm Res; 1992; 37(6):217-20. PubMed ID: 1292974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proinflammatory cytokine levels in hyperthyroidism.
    Senturk T; Kozaci LD; Kok F; Kadikoylu G; Bolaman Z
    Clin Invest Med; 2003 Apr; 26(2):58-63. PubMed ID: 12722837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment].
    Chai R; Ye Z; Zhan Z
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid uptake of radioactive iodine in hyperthyroidism.
    Hooper PL; Caplan RH
    JAMA; 1977 Aug; 238(5):411-3. PubMed ID: 577556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Osteocalcin and hyperthyroidism].
    Pandolfi C; Montanari G; Mercantini F; Sbalzarini G
    Minerva Endocrinol; 1992; 17(2):75-8. PubMed ID: 1296147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical hyperthyroidism of variable etiology and its influence on bone in postmenopausal women.
    Belaya ZE; Melnichenko GA; Rozhinskaya LY; Fadeev VV; Alekseeva TM; Dorofeeva OK; Sasonova NI; Kolesnikova GS
    Hormones (Athens); 2007; 6(1):62-70. PubMed ID: 17324919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism.
    Koukkou E; Panayiotidis P; Alevizou-Terzaki V; Thalassinos N
    J Clin Endocrinol Metab; 1991 Oct; 73(4):771-6. PubMed ID: 1909702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hyperthyroidism and its treatment on bone mineral content.
    Toh SH; Claunch BC; Brown PH
    Arch Intern Med; 1985 May; 145(5):883-6. PubMed ID: 3838875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.